α2-Adrenergic receptor sensitivity in panic disorder: I. GH response to GHRH and clonidine stimulation in panic disorder

F. Brambilla, G. Perna, A. Garberi, P. Nobile, L. Bellodi

Research output: Contribution to journalArticlepeer-review

Abstract

Baseline levels of GH and somatomedin C (SmC) and GH responses to GHRH (1 μg/kg b.w.) and to clonidine (150 μg) were measured in 10 outpatients with panic disorder before and after 30 days of 2-2.5 mg of alprazolam therapy, and in 10 psychophysically healthy controls. Basal levels of GH were normal in the patients and those of SmC significantly elevated, both before and after therapy. Basal GH responses to GHRH stimulation were normal and did not change after alprazolam treatment. Basal GH responses to clonidine stimulation were blunted in the patients and improved after therapy, in parallel with an amelioration of the psychopathology. Our data suggest that adrenoceptor sensitivity, investigated by the clonidine test, is reduced in panic disorder.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalPsychoneuroendocrinology
Volume20
Issue number1
DOIs
Publication statusPublished - 1995

Keywords

  • Alprazolam
  • Clonidine test
  • GHRH test
  • Growth hormone
  • Somatomedin C
  • α-Adrenoceptors

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Endocrine and Autonomic Systems
  • Psychology(all)

Fingerprint Dive into the research topics of 'α2-Adrenergic receptor sensitivity in panic disorder: I. GH response to GHRH and clonidine stimulation in panic disorder'. Together they form a unique fingerprint.

Cite this